First day gains for Alphamab Oncology reflect Hong Kong exchange’s growing momentum

By Hongjiang Li, Staff Writer | Dec 13, 2019 | 12:53 AM GMT

Double digit gains by Alphamab Oncology are the latest sign that Hong Kong’s biotech chapter has shrugged off mid-year doldrums and uncertainty caused by ongoing protests. Alphamab Oncology Ltd. (HKEX:9966) rose HK$3.30 (32%) to HK$13.50 in its first day of trading Thursday, adding HK$3 billion to its market cap.

The company